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Sex-related differences in carotid plaque features
and inflammation
Giuseppe Sangiorgi, MD,a Sara Roversi, MD,b Giuseppe Biondi Zoccai, MD,c
Maria Grazia Modena, MD, FACC, FESC,b Francesca Servadei, MD,d Arnaldo Ippoliti, MD,e and
Alessandro Mauriello, MD,d Rome, Modena, and Latina, Italy
Objective: Severe carotid stenosis is a frequent cause of stroke in both men and women. Whereas several sex-related
comparisons are available on coronary atherosclerosis, there are few data appraising gender-specific features of carotid
plaques. We aimed to systematically compare the pathology and inflammatory features of carotid plaques in men vs
women.
Methods:Carotid plaque specimens were collected from patients undergoing surgical endarterectomy for asymptomatic or
symptomatic carotid stenosis. Histologic analysis was performed, as well as measurements of plaque composition and
inflammation.
Results: A total of 457 patients were included (132 women, 325 men). Baseline analyses showed a greater prevalence of
hypercholesterolemia, hypertension, and former smoking status in women, despite a higher Framingham Heart Score in
men (all P < .05). Women had a lower prevalence of thrombotic plaques, smaller percentage area of necrotic core, and
hemorrhage extension (all P< .05). Plaque inflammation analysis showed a lower concentration of inflammatory and, in
particular, of macrophage foam cells in the plaque cap of women (both P < .05). These differences were, however, no
longer significant at multivariable analysis, including several baseline features, such as symptom status and stenosis
severity.
Conclusions: Carotid plaques seem significantly different in women and men, but the main drivers of such pathologic
differences are baseline features, including stenosis severity and symptom status. ( J Vasc Surg 2013;57:338-44.)
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eIt is well recognized that cardiovascular diseases
(CVDs) represent an important burden in Western society.
An estimated 82million Americans have at least one type of
CVD, and of these, about 7 million have had a stroke.
Statistics have shown that the vast majority of stroke is
caused by ischemia (87% compared to 13% of intracerebral
or subarachnoid hemorrhages).1
It is now widely accepted that carotid atherosclerosis
and subsequent stenosis is a relevant cause of ischemic
stroke.2 Carotid atheroma was described as a possible cause
of stroke already at the beginning of the century, and this
was finally proven by large multicenter trials demonstrating
stroke reduction after carotid endarterectomy (CEA) of
severe stenosis.3-7 However, men and women are not af-
fected in the same way1 and gender difference has been
reported for stroke as well as for other CVDs.8-10 Even
though many authors have focused their attention on ca-
rotid atherosclerosis, just a few works have addressed sex-
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338elated differences in this vascular bed. Thus, most of our
nowledge on gender difference in atherosclerosis derives
rom analysis carried out on coronary arteries.11,12 In par-
icular, it is well recognized that men develop active coro-
ary atherosclerosis and associated acute lesions earlier in
ife, whereas premenopausal women seem to be more resis-
ant to coronary artery disease (CAD). Moreover, athero-
clerosis in men presents distinct inflammatory and histo-
ogic features when compared to women.13-15 Because
elevant gender-related differences have been high-
ighted in coronary arteries, could the same be true in
arotid vessels? Thus, we aimed to systematically compare
arotid plaque specimens derived from CEA of both men
nd women to search for sex-related distinctions in plaque
orphology.
ETHODS
Case selection. Our population comprised a total of
57 specimens from symptomatic (major stroke or tran-
ient ischemic attack [TIA]) and asymptomatic patients
ubmitted to surgical CEA at the University of Tor Vergata
Rome, Italy). Informed consent was obtained from the
ubjects for data collection.
The sampling collection and analysis methods have
een previously reported.16 Data regarding patient presen-
ation, including risk factors and symptoms were recorded.
ypertension, hyperlipidemia, and diabetes were defined
y case history, drug treatment, or available analysis.
Previous CAD and obstructive peripheral vascular dis-
ase, coronary artery bypass graft, and preoperative use of
spirin and statins were assessed from clinical history. Hy-
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Volume 57, Number 2 Sangiorgi et al 339pertension was diagnosed in patients with positive clinical
history of systolic blood pressure 140 mm Hg and/or a
diastolic blood pressure 90 mm Hg, or those receiving
antihypertensive treatment at the time of CEA. Diabetes
mellitus was diagnosed in patients with fasting blood glu-
cose 126 mg/dL and/or on oral treatment or insulin
therapy. Patients with tobacco dependence were catego-
rized as smokers and former smokers. Former smokers who
had stopped smoking for 5 years were considered as
smokers and patients who had not smoked for 15 years
were considered as nonsmokers. Hypercholesterolemia was
diagnosed in those with total cholesterol level 200
mg/dL (5.18 mmol/L), regardless of statin therapy.
Patients were defined as with low high-density lipoprotein-
cholesterol if this was 40 mg/dL in men or 50 mg/dL
in women. Hypertriglyceridemia was diagnosed in patients
with serum triglycerides levels 150 mg/dL (1.70
mmol/L). Abdominal obesity was diagnosed in patients
with a waist circumference 102 cm in men or 88 cm in
women. In addition, the Framingham Risk Score was cal-
culated using an algorithm that included age, gender,
smoking status, and presence of diabetes as dichotomous
parameters, as well as total cholesterol, high-density lipo-
protein-cholesterol, and diastolic and systolic blood pres-
sure using the categories defined in the Framingham equa-
tion.
Major stroke was defined as a clinical syndrome charac-
terized by rapidly developing focal or global symptoms in
the distribution of symptomatic carotid artery, without
significant clinical improvement within 7 days; stroke had
to be of vascular origin, and other causes as hemorrhage
were excluded by brain computed tomography study. TIA
was defined as recent (120 days before surgery) occur-
rence of any sudden focal neurological deficit that disap-
peared completely within 24 hours, without previous
stroke. Asymptomatic patients never reported neurological
symptoms or cerebral lesions at computed tomography. All
asymptomatic patients showed a carotid stenosis 60%.
Stenosis severity was appraised with both North American
Symptomatic Carotid Endarterectomy Trial criteria and at
pathology.
Histology. Intraoperatively, carotid plaques were re-
moved en bloc by conventional arteriotomy to preserve
entire plaque structure, as previously reported.16 When a
carotid sample was fragmented, the case was excluded from
the study. Thus, only intact cases were analyzed. Then,
samples were fixed immediately upon removal in 10% buff-
ered formalin for 24 hours. After decalcification, if neces-
sary, specimens were cut transversely every 5 mm, embed-
ded in paraffin, and stained with hematoxylin-eosin and
Movat pentachrome stains. Each segment was removed and
numbered sequentially to reconstruct the entire plaque
length by sequential slices. For each plaque, three to 10
sections were examined according to the extension of the
plaque (mean 5 sections per artery). In this way, the entire
plaque was evaluated for the presence of an acute or orga-
nized thrombosis, plaque rupture or erosion, extension of
necrotic core, calcification, and intraplaque hemorrhage. owo pathologists evaluated all histologic components (in-
raobserver and interobserver reliability 98%). The pres-
nce of acute or organized thrombosis, plaque rupture or
rosion, extension of necrotic core, calcification, and intra-
laque hemorrhage was evaluated for each plaque. The
mmunohistochemical study characterized inflammatory
ells present in the cap of ruptured plaques, using the
D68 and CD3 monoclonal antibodies. Cell counting was
erformed at a magnification of400 using a test grid with
n area of 0.22mm2. An average of 10 fields per section was
ounted.
Plaque classification. Plaques were classified accord-
ng to themodified AmericanHeart Association atheroscle-
osis classification12,16 into three categories: thrombotic,
ulnerable, and stable plaques. Thrombotic plaques in-
luded the following plaque types: (a) plaque rupture with
uminal thrombus, (b) ulceration, (c) erosion, (d) calcified
odule, and (e) organizing thrombus. Vulnerable plaque or
hin-cap fibro-atheroma (TCFA) was characterized by a
brous cap 165 m thick heavily infiltrated by macro-
hages, CD68 positive (25 per high magnification field),
ithout plaque rupture.17 Specifically, as reported previ-
usly,16 a thrombotic plaque was defined by the presence of
n acute thrombus constituted of platelets or fibrin on the
laque surface, and characterized by lamination with or
ithout red and white interspersed cells. Thrombosis was
ivided into two categories: (1) thrombosis associated with
laque rupture and (2) erosion. Plaque rupture was defined
s a complete disruption of the fibrous cap over a lipid core
ith contact of an acute thrombus with the lipid pool.
uperficial erosion was defined as plaque disendotheliza-
ion, associated with the presence of an acute thrombus in
irect contact with the subepithelial tissue of the cap with-
able I. Baseline features
Women
(n  132)
Men
(n  325) P value
ge (years) 69.9  7.2 69.6  7.0 .768
moking history .002
Current 32 (24.2%) 96 (29.5%)
Former 71 (53.8%) 117 (36.0%)
Ever 29 (22.0%) 112 (34.5%)
ypercholesterolemia 89 (67.4%) 183 (56.3%) .028
ypertension 61 (67.0%) 121 (53.1%) .023
erum fibrinogen
(mg/dL) 365.1  140.6 335.3  93.0 .420
otal number of risk
factors 2.9  1.4 2.7  1.5 .228
HS 17.3  7.4 27.3  11.3 .001
tatin therapy 42 (35.6%) 87 (29.6%) .277
ymptomatic status .178
Asymptomatic 71 (53.8%) 149 (45.8%)
TIA 27 (20.5%) 92 (28.3%)
Stroke 34 (25.8%) 84 (25.8%)
tenosis severity at
preoperative
assessment 84.7%  9.2% 84.3%  9.8% .741
HS, Framingham Heart Score; TIA, transient ischemic attack.ut any contact with the lipid pool demonstrated in serial
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February 2013340 Sangiorgi et alsections. Organized thrombus was characterized by fibrous
tissue, sometimes stratified, associated with a typical angi-
omatosis, with a network of large, thin-walled vascular
channels, and a variable number of macrophagic cells
loaded with hemosiderin, visible as scattered brown refrac-
tive pigments. Stable plaques were divided in fibrocalcific
and healed plaques. Fibrocalcific plaques showed a thick
fibrous cap (165 m) associated to the presence of calci-
fication and a variable necrotic core. Healed plaques were
defined as those showing multilayers of fibrous tissue and
lipid rich necrotic core.
Statistical analysis. Data were analyzed using SPSS
version 11.0 (SPSS, Chicago, Ill) software. The Pearson 2
test was used to assess the differences in the frequency of
thrombosis, cap rupture and cap erosion, and risk factors
between the groups. The t-test for unpaired samples was
used to evaluate differences in age, grade of angiographic
stenosis, and degree of inflammatory infiltrate between the
groups. Multivariable linear regression analysis was per-
formed to adjust bivariate estimates, including all covariates
associated at bivariate analyses with gender with P  .10:
smoking status, hypercholesterolemia, hypertension, Fra-
mingham Heart Score (FHS), plaque classification, throm-
botic plaque, percentage area of necrotic lipid core, and
hemorrhage extension, plus stenosis severity and symptom
status, given their pivotal importance in carotid atheroscle-
rosis, and R2 was computed using gender as the only
independent variable. Any P value  .05 was considered
Table II. Plaque features
W
(n
Plaque location
Common carotid 12
Bifurcation 22
Internal carotid 8
Plaque classification
Rupture with luminal thrombus 11
Ulceration 19
Erosion
Calcified nodule 7
Organized thrombus 7
TCFA 22
Healed plaque 15
Stable fibrocalcific 51
Any thrombotic plaques 44
Minimum cap thickness (m) 143.
Percentage area of necrotic lipid core 49.
Calcium-lumen distance (m) 866.
Calcified area
5% of plaque area 41
1%-5% of plaque area 11
No calcifications 12
Hemorrhagic area
10% of plaque 26
1%-10% of plaque 15
No hemorrhage 20
TCFA, Thin-cap fibroatheroma.statistically significant. 8ESULTS
Risk factors. A total of 457 patients were included,
32 women and 325 men. Baseline features are summa-
ized in Table I. Mean age was 69 years and was not
tatistically different between groups. Cardiovascular
isk factors were recorded and the total number of risk
actors per patient showed no statistical difference (P 
228). However, specific risk factors differed significantly
etween genders: men had a higher prevalence of current
nd previous smoking, whereas women presented with
igher incidence of hypercholesterolemia, hypertension,
nd former smoking history (all P  .05). Despite this,
en had a higher FHS (P  .001). Fibrinogen serum
evels did not differ between men and women (P 
420). Approximately one third of patients were on statin
herapy, with no significant difference (P  .277).
laque thrombosis location was mainly at the bifurcation
ite in both genders. The maximal luminal stenosis
howed no significant difference between men and
omen (P  .742).
Stenosis severity at preoperative assessment was
4.3%  9.8% in men and 84.7%  9.2% in women (P 
74). Further analysis according to symptom status
ielded the following results: 84.5%  8.4% for asymp-
omatic disease, 81.7%  10.9% for TIA, and 85.5% 
0.5% for stroke in men, and 82.4%  9.5% for asymp-
omatic disease, 88.5%  6.3% for TIA, and 87.4% 
n
2)
Men
(n  325) P value
.687
%) 28 (21.7%)
%) 75 (58.1%)
%) 24 (18.6%)
.034
) 25 (7.7%)
%) 67 (20.6%)
1 (0.3%)
) 7 (2.2%)
) 37 (11.4%)
%) 50 (15.4%)
%) 52 (16.0%)
%) 86 (26.5%)
%) 137 (49.8%) .013
17.8 131.7  94.1 .612
8.7 56.2  17.7 .010
21.5 1458.5  1461.6 .144
.227
%) 85 (51.5%)
%) 40 (24.2%)
%) 40 (24.2%)
.022
%) 98 (63.2%)
%) 23 (14.8%)
%) 34 (21.9%)ome
 13
(28.6
(52.4
(19.0
(8.3%
(14.4
0
(5.3%
(5.3%
(16.7
(11.4
(38.6
(40.0
2  1
2  1
7  7
(64.1
(17.2
(18.8
(42.6
(24.6
(32.8.6% for stroke in women (P  not significant).
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Volume 57, Number 2 Sangiorgi et al 341Histologic examination. The most relevant features
derived from carotid plaque specimens’ analysis are re-
ported in Table II.
Types of atherosclerotic plaques had distinct features
showing a relevant gender difference (P  .034). Throm-
botic plaques were significantly more represented in men
(P  .013). In particular, plaque ulceration was found
more often in men. On the contrary, women had a higher
degree of calcific nodules. Approximately 16% of women
and 15% of men had vulnerable TCFA, whereas stable
fibrocalcific plaque was evidently more frequent in women
(38% compared to 26% of male patients).
Regarding the histologic plaque composition, the per-
centage of necrotic lipid core was higher inmen (P .010),
and the same results were obtained regarding hemorrhagic
area of the plaque (P  .022). Instead, no statistical differ-
ence emerged in the minimum cap thickness, but a trend
placing men in the higher risk group was noted. No differ-
ence was found in calcium-lumen distance analysis or in the
percentage of calcified area as well, with both genders
presenting variable degrees of calcium in the plaque.
Subsequent analyses were performed to determine
Table III. Plaque inflammation features at bivariate analys
Overall analysis
Plaque inflammation (CD68 and CD3 positive cells in the plaqu
Cap inflammation (CD68 and CD3 positive cells in the cap/mm
Foam cells (CD68 positive) in the cap/mm2
T-lymphocytes (CD3 positive) in the cap/mm2
Asymptomatic patients
Plaque inflammation (CD68 and CD3 positive cells in the plaqu
Cap inflammation (CD68 and CD3 positive cells in the cap/mm
Foam cells (CD68 positive) in the cap/mm2
T-lymphocytes (CD3 positive) in the cap/mm2
Patients with TIA
Plaque inflammation (CD68 and CD3 positive cells in the plaqu
Cap inflammation (CD68 and CD3 positive cells in the cap/mm
Foam cells (CD68 positive) in the cap/mm2
T-lymphocytes (CD3 positive) in the cap/mm2
Patients with stroke
Plaque inflammation (CD68 and CD3 positive cells in the plaqu
Cap inflammation (CD68 and CD3 positive cells in the cap/mm
Foam cells (CD68 positive) in the cap/mm2
T-lymphocytes (CD3 positive) in the cap/mm2
Patients with 50% to 69% stenosis
Plaque inflammation (CD68 and CD3 positive cells in the plaqu
Cap inflammation (CD68 and CD3 positive cells in the cap/mm
Foam cells (CD68 positive) in the cap/mm2
T-lymphocytes (CD3 positive) in the cap/mm2
Patients with 70% to 89% stenosis
Plaque inflammation (CD68 and CD3 positive cells in the plaqu
Cap inflammation (CD68 and CD3 positive cells in the cap/mm
Foam cells (CD68 positive) in the cap/mm2
T-lymphocytes (CD3 positive) in the cap/mm2
Patients with 90% stenosis
Plaque inflammation (CD68 and CD3 positive cells in the plaqu
Cap inflammation (CD68 and CD3 positive cells in the cap/mm
Foam cells (CD68 positive) in the cap/mm2
T-lymphocytes (CD3 positive) in the cap/mm2
TIA, Transient ischemic attack.plaque inflammation features, and results are listed in Table flII and Table IV. Relevant gender difference was recorded
egarding the amount of inflammatory cells (macrophages
nd T-lymphocytes) present in the entire plaque (P .017)
nd, in particular, in the cap (P  .028). The increase of
nflammation observed in plaques from men was mainly
ue to increase of macrophage foam cells (P  .009).
Despite these apparent differences between men and
omen, multivariable analysis adjusted for cardiovascular
isk factors, FHS, plaque features, stenosis severity, and
ymptom status showed that gender was no longer signifi-
antly associated with plaque inflammation features, thus
uggesting that the above differences were largely driven by
aseline factors, including stenosis severity and symptom
tatus (Table IV).
ISCUSSION
This study was designed to test the hypothesis that
arotid plaques differ between men and women. Women,
ll postmenopausal and not on hormone replacement ther-
py, as compared to men of the same age, had a lower
revalence of thrombotic plaques, and a smaller area of
ecrotic core and hemorrhage extension. Moreover, in-
the overall cohort and in key subgroups
Women Men P value
m2) 29.3  20.0 36.3  20.4 .017
26.0  20.2 34.1  25.8 .028
19.3  16.0 27.1  22.7 .009
8.5  9.9 7.4  6.1 .541
m2) 15.5  10.5 26.6  15.7 .001
13.9  10.9 22.2  14.4 .009
10.2  7.4 16.6  10.4 .008
4.9  5.9 5.4  4.6 .682
m2) 25.6  19.4 35.0  16.0 .117
27.0  26.9 29.1  14.6 .836
18.9  9.1 22.3  14.3 .694
16.7  21.5 6.7  6.5 .134
m2) 46.5  15.2 47.6  21.5 .813
42.0  18.2 47.9  31.0 .417
30.1  17.7 37.4  27.7 .264
12.3  11.4 9.5  6.5 .200
m2) 22.6  22.9 35.1  15.8 .205
19.6  24.9 34.7  14.4 .115
12.7  14.1 27.5  13.6 .073
6.9  11.1 8.4  4.0 .664
m2) 28.2  14.2 32.6  21.4 .439
27.2  16.4 28.6  23.7 .828
21.9  12.2 21.9  19.9 .994
9.2  5.4 6.8  6.1 .192
m2) 27.4  19.5 25.8  22.2 .017
25.8  22.2 36.1  25.8 .077
18.9  19.2 28.8  22.1 .052
8.0  11.3 7.7  6.6 .876is in
e/m
2)
e/m
2)
e/m
2)
e/m
2)
e/m
2)
e/m
2)
e/m
2)ammatory features were less pronounced, thus confirming
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February 2013342 Sangiorgi et althe presence of gender-related differences, even if such
differences were apparent only at bivariate analyses, and
were no longer significant at multivariable analyses adjust-
ing for other baseline variables, including symptom status
and stenosis severity.
Gender differences in coronary vs carotid arteries.
Gender difference in CVD is now widely accepted. Sex
hormones seem to play a fundamental protective role in
women through widespread actions, affecting endothelial
function, lipid homeostasis, and cardiovascular risk factor
reduction.18-21 Moreover, some authors claim that estro-
gens might have plaque stabilization properties and effects
on inflammatory status.22,23 Previous histologic studies
have demonstrated that in earlier stages of CAD, men
presented more severe atheroma burden, and more diffuse
endothelial dysfunction.11,24 This difference seemed to
decline over time, as atherosclerotic coronary plaques in
postmenopausal women were shown to be similar to those
of men and differed from those of women of childbearing
age.22
Thus, estrogen role on coronary endothelium is not
clearly defined yet. Trials on hormone replacement therapy
have yielded contrasting results, without the clear cardio-
vascular benefit that was initially expected.25 This has led
many authors to speculate a possible age-dependent effect
of estrogens, which reduces inflammation in younger age,
while having opposite effects in older women.15,26 How-
ever, similar results have not been reported on carotid
arteries. On the contrary, estrogens seem to have mainly
stabilizing and protective properties.16,27,28 A recent ultra-
sound scan analysis recruiting over 1600 patients has doc-
umented significant lower plaque burden in women. The
authors speculated that estrogensmight act not only on risk
factor reduction, but also directly on plaque morphology
and arterial remodeling.23 Subsequent trial comparing
plaque features by means of histologic analysis or magnetic
resonance imaging reported similar findings (ie, more in-
flammatory and high-risk features in men compared to
women).28-30 Thus, current evidence points toward a last-
ing protective effect of sex hormones in women in carotid
arteries, slightly different from what has been reported on
coronary arteries.
Gender differences in inflammatory features. Athe-
rosclerotic plaque growth is a complex process. Plaques differ
one another, with some of them leading to fatal events,
whereas others remain stable and silent for many years.12
Clinicopathological studies have identified a wide spectrum
of alterations involving plaque surface, but eventually rup-
ture of the fibrous cap is the triggering event for intravessel
thrombosis and subsequent clinical events.31-34 Thus, the
vulnerable and rupture-prone plaque presents high fat con-
tent, high density of inflammatory features, thin fibrous
cap, and low collagen and smooth muscle cells.16,35,36
Estrogens play a fundamental role on most aspects of
plaque growth, conferring a cardiovascular advantage in
women, at least in younger age.37 Our results further
confirm these findings, correlating gender difference with
vulnerable plaque features. Our population was substan- Hially similar regarding major baseline characteristics and
verall number of risk factors, symptomatic status, and
tatin therapy. Moreover, our patients had no significant
ifference in plaque location among men and women.
owever, plaque features were significantly different.
First of all, plaques in men seemed more complex, with
igher rates of erosion, ulceration, and subsequent healing.
n the contrary, women had higher rates of stable fibro-
alcific plaques. Furthermore, thrombus burden, hemor-
hagic areas, and necrotic lipid core were significantly
igher in men. Distinctive inflammatory features,38,39 rep-
esented by concentration of foam cells or lymphocytes in
he cap were significantly lower in women.
This further supports previous findings, suggesting that
n women, sex hormones play a protective role, maybe
hrough plaque stabilization.Moreover, because all women
ere postmenopausal, the protective effect of estrogen on
he carotid vascular bed might linger longer than in the
oronary artery.
A recent systematic review has investigated outcomes in
en and women after CEA, focusing on causal gender-
elated factors.40 As expected, only a few trials were avail-
ble addressing this topic. Plaque morphology was sug-
ested as a gender-specific characteristic influencing
utcomes after CEA, and in line with our findings, wom-
n’s plaques were reported to have more stable character-
stics than men’s. Thus, the difference between men and
omen should not be forgotten even when planning
reatment strategy, as gender-related characteristics
eem to be related to clinical outcome.
Further studies are required to appraise in detail the
mplications of our study findings on patient management.
able IV. Plaque inflammation features at multivariable
nalysisa
R2
Regression coefficient
(95% CI)
P
value
laque inflammation
(CD68 and CD3
positive cells in the
plaque/mm2) 2.4% 3.6 (2.8 to 10.1) .268
ap inflammation
(CD68 and CD3
positive cells in the
cap/mm2) 2.8% 2.3 (10.3 to 5.8) .582
oam cells (CD68
positive) in the
cap/mm2 2.3% 0.48 (7.5 to 6.6) .133
-lymphocytes (CD3
positive) in the
cap/mm2 0.4% 2.4 (5.4 to 0.7) .124
I, Confidence interval; FHS, Framingham Heart Score.
Adjusting for all variables included in Tables I to II and associated at
ivariate analyses with gender with P  .10: smoking status, hypercholes-
erolemia, hypertension, FHS, plaque classification, thrombotic plaque,
ercentage area of necrotic lipid core, hemorrhage extension, plus stenosis
everity and symptom status. R2 was computed using a gender as the only
ndependent variable; female gender was coded as 2, and male gender as 1.owever, we may speculate that gender, together with
11
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Volume 57, Number 2 Sangiorgi et al 343other very important patient and lesion factors (such as
symptom status and stenosis severity), should be taken into
account for medical decision-making and risk-stratification.
For instance, women and/or those with recent neurologic
symptoms might benefit from high-dose preoperative sta-
tin therapy or could be considered potentially more suitable
for surgical rather than endovascular therapy.
Limitations. Our study was not designed to test
causal relationships or clinical implication of sex-related
differences, or to evaluate estrogen levels in our population,
thus remaining a descriptive and hypothesis-generating
work. Moreover, it is still unclear how estrogen protection
acts on the vascular bed, and how long this protection lasts.
Therefore, gender-related differences are still far from be-
ing fully explained. Notably, our cases were all submitted to
surgery after 30 days from symptoms onset. If we use a
30-day cutoff (instead of 120-day cutoff) to distinguish
asymptomatic from symptomatic patients, all symptomatic
plaques can be now be considered asymptomatic. Thus, the
histomorphologic analysis hereby provided would yield the
exact same results. We also considered in the group of
thrombotic plaques those with organized thrombus. In this
latter case, we considered the event of plaque thrombosis
unrelated to the time of occurrence. Therefore, we did not
underestimate the most important morphologic feature
related to a clinical event. Finally, we did not perform
systemic biomarker screening or noninvasive imaging to
characterize high-risk plaque morphology because it was
out of the scope of the present histopathology study.
However, pathology may still be considered the gold stan-
dard for plaque characteristics of vulnerability.
CONCLUSIONS
Carotid plaques seem significantly different in women
and men, but the main drivers of such pathologic differ-
ences are baseline feature, including stenosis severity and
symptom status.
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